Related Experiment Video
Updated: Aug 11, 2026

08:01
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Allergic bronchopulmonary aspergillosis: serologic update for 1995
J Krasnick1, P A Greenberger, M Roberts
1Department of Medicine, Northwestern University Medical School, Chicago, Illinois, USA.
Summary
Diagnosing allergic bronchopulmonary aspergillosis (ABPA) relies on serologic tests. Total IgE, IgE antibody index, and precipitins are consistently positive, aiding ABPA diagnosis and monitoring.
Area of Science:
- Pulmonology
- Immunology
- Allergy
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) affects 1-2% of asthma patients.
- ABPA involves hypersensitivity to Aspergillus species.
- Diagnosis requires clinical history and serologic tests.
Purpose of the Study:
- To compare initial and recent serologic test results in ABPA patients.
- To evaluate the consistency of four key serologic markers in diagnosing and monitoring ABPA.
- To determine the diagnostic utility of total serum IgE, IgE and IgG antibody indices, and serum precipitins for Aspergillus fumigatus.
Main Methods:
- Retrospective analysis of initial and recent serology in ABPA patients.
- Comparison of four serologic tests: total serum IgE, IgE antibody index, IgG antibody index, and serum precipitins.
- Assessment of test positivity throughout disease treatment and monitoring.
Main Results:
- Total serum IgE, IgE antibody index, and serum precipitins demonstrated sustained positivity.
- The IgG antibody index showed the most inconsistency.
- No significant differences were found in the overall diagnostic performance between the four tests.
Conclusions:
- All four serologic tests are crucial for accurate ABPA diagnosis.
- Sustained positivity of total IgE, IgE index, and precipitins supports their role in monitoring.
- Consistent evaluation of all four markers is recommended for comprehensive ABPA management.

